These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 433309

  • 1. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME, Ilett KF.
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [Abstract] [Full Text] [Related]

  • 2. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O, Sotaniemi E, Tokola O, Ahokas JT.
    Drug Metab Dispos; 1980 Feb; 8(4):218-22. PubMed ID: 6105054
    [Abstract] [Full Text] [Related]

  • 3. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
    Brouwer KL, Kostenbauder HB, McNamara PJ, Blouin RA.
    J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
    [Abstract] [Full Text] [Related]

  • 4. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet.
    Gadeholt G, Aarbakke J, Dybing E, Sjöblom M, Mørland J.
    J Pharmacol Exp Ther; 1980 Apr; 213(1):196-203. PubMed ID: 6102148
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mixed function oxidase activity in a marsupial. The quokka (Seton;x brachyurus).
    McManus ME, Ilett KF.
    Drug Metab Dispos; 1976 Apr; 4(3):199-202. PubMed ID: 6222
    [Abstract] [Full Text] [Related]

  • 8. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital.
    Robertson IG, Serabjit-Singh C, Croft JE, Philpot RM.
    Mol Pharmacol; 1983 Jul; 24(1):156-62. PubMed ID: 6865923
    [Abstract] [Full Text] [Related]

  • 9. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D, Miguet JP, Camelot G, Delafin C, Joanne C, Bechtel P, Gillet M, Carayon P.
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [Abstract] [Full Text] [Related]

  • 10. Species differences in benzene hydroxylation to phenol by pulmonary and hepatic microsomes.
    Harper C, Drew RT, Fouts JR.
    Drug Metab Dispos; 1975 Jan; 3(5):381-8. PubMed ID: 241619
    [Abstract] [Full Text] [Related]

  • 11. Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450.
    Kokkinakis DM, Koop DR, Scarpelli DG, Coon MJ, Hollenberg PF.
    Cancer Res; 1985 Feb; 45(2):619-24. PubMed ID: 3967237
    [Abstract] [Full Text] [Related]

  • 12. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene.
    Burke MD, Mayer RT.
    Drug Metab Dispos; 1974 Feb; 2(6):583-8. PubMed ID: 4155680
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL, Novak RF.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [Abstract] [Full Text] [Related]

  • 14. The effect of isolation stress on some hepatic drug and carcinogen metabolising enzymes in rats.
    Capel ID, Jenner M, Pinnock MH, Dorrell HM, Williams DC.
    J Environ Pathol Toxicol; 1980 Sep; 4(2-3):337-44. PubMed ID: 7193236
    [Abstract] [Full Text] [Related]

  • 15. [Sexual variations in the metabolism of antipyrine in vivo and in vitro].
    Salvá P, Salvá JA, Laporte J.
    Arch Farmacol Toxicol; 1978 Apr; 4(1):116-9. PubMed ID: 697376
    [No Abstract] [Full Text] [Related]

  • 16. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN, Himes JA, Edds GT.
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract] [Full Text] [Related]

  • 17. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF, Skinner MH, Blaschke TF.
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [Abstract] [Full Text] [Related]

  • 18. Exercise training does not alter cytochrome P-450 content and microsomal metabolism.
    Michaud TJ, Bachmann KA, Andres FF, Flynn MG, Sherman GP, Rodriguez-Zayas J.
    Med Sci Sports Exerc; 1994 Aug; 26(8):978-82. PubMed ID: 7968432
    [Abstract] [Full Text] [Related]

  • 19. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA, Shand DG, Wilkinson GR, Nies AS.
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
    Kahn GC, Boobis AR, Murray S, Davies DS.
    Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.